Source Naturals Dihydroberberine 200mg
A 200 mg dihydroberberine capsule from an established supplement brand, published in 30 and 60 count sizes. The copy is more precise than most in this category: it distinguishes between berberine's support for the GLP-1 pathway and dihydroberberine's AMPK activation rather than collapsing the two, and it explains the absorption and digestive-comfort rationale for the DHB form specifically.
Last reviewed · researched from the manufacturer’s published pages by Tom
What’s in it
Amounts are shown only where the manufacturer publishes them. Anything without a figure is undisclosed — and for an active ingredient, an undisclosed dose is the central problem with this category.
- Dihydroberberine (DHB)200 mg per capsule
Patented form of berberine, described as clinically shown to have five times greater absorption
How the manufacturer says it works
Source Naturals describes DHB as the patented, evolved form of berberine, clinically shown to have five times greater absorption with a longer half-life, promoting GI health and comfort at a lower potency. It states that berberine on its own can help support the GLP-1 pathway and that DHB has been studied in human and preclinical models to additionally help activate the AMPK pathway, and pairs the product with its own diet plan.
What the evidence actually supports
Publishing a specific per-capsule amount of a named form is the baseline this category often fails to meet, and doing it across two pack sizes makes cost comparison easy. The absorption argument for DHB is real: standard berberine is poorly absorbed and causes GI upset at effective doses, which is the ingredient's central practical problem, and DHB was developed as the answer. Berberine's own literature — meta-analyses generally showing modest improvements in fasting glucose, HbA1c and lipids — is the strongest in this category. The copy is also unusually careful in separating the GLP-1 pathway claim from the AMPK claim rather than merging them.
Where that evidence stops
The primary mechanism is AMPK, not the GLP-1 receptor, so this is not comparable to a GLP-1 medication regardless of the pathway language. Effects on body weight specifically are much smaller and less consistent than effects on glucose markers. The five-times absorption figure and the human studies are referenced but not identified on the page we captured, so they cannot be read. Most importantly berberine and its metabolites inhibit CYP3A4 and other drug-metabolising enzymes, and can raise blood levels of many common prescription medicines — that is a pharmacist conversation before purchase, not after. The accompanying diet plan means some of the promised benefit is attributed to eating changes rather than the capsule.
Strengths and problems
Strengths
- Publishes a specific 200 mg per-capsule dose across two pack sizes
- Separates the GLP-1 pathway claim from the AMPK claim instead of conflating them
- Explains the digestive-comfort rationale for DHB over standard berberine
- Established brand with a long track record in the category
Problems
- The absorption and human study claims are referenced but not identified
- AMPK is not a GLP-1 mechanism, despite the aisle this sits in
- Real interaction risk with many prescription medications via CYP3A4
- Directions, warnings, allergens, testing and refund terms were not published on the page we captured
- Benefits are framed alongside the brand's own diet plan, which confounds what the capsule contributes
What the manufacturer publishes
Publishes 1 of 8 standard terms.
- Intended use
- Sold as a dietary supplement for weight management, carbohydrate and fat metabolism and energy support, not as a treatment for any condition.
- Directions
- Not publicly disclosed on the pages we captured.
- Warnings
- Not publicly disclosed on the pages we captured.
- Allergens
- Not publicly disclosed on the pages we captured.
- Third-party testing
- Not publicly disclosed on the pages we captured.
- Pricing
- $23.98 for 30 vegetarian capsules and $45.98 for 60 at capture.
- Subscription
- Not publicly disclosed on the pages we captured.
- Refunds
- Not publicly disclosed on the pages we captured.
- Shipping
- Not publicly disclosed on the pages we captured.
May suit
Someone who wants a labelled, mid-priced dihydroberberine from an established brand and has cleared it with a pharmacist.
Do not use if
- You take any prescription medication and have not checked interactions with a pharmacist
- You take glucose-lowering medication — additive hypoglycaemia risk
- You are pregnant or breastfeeding
- You expect an effect comparable to a prescription GLP-1
Frequently asked
Does berberine support the GLP-1 pathway?
There is some preclinical work suggesting berberine influences GLP-1 secretion, and Source Naturals phrases it carefully as support for the pathway rather than claiming a drug-like effect. The main established mechanism is AMPK activation, which is a different route entirely. Neither produces anything close to what a GLP-1 receptor agonist does — the distinction between influencing a pathway and pharmacologically activating a receptor is the whole difference between this and a prescription.
Sources
Captured . Manufacturer pages change — check the current version before relying on anything.